Mirati Therapeutics
IRS: 462693615MRTX
Mirati Therapeutics Inc is a clinical-stage oncology company developing novel therapeutics to address the genetic and immunological promoters of cancer. It operates in a single geographical segment being the United States.
Founded
2013 (10 years)
Revenue
12 million (2022)